Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Hypertension (Dallas, Tex. : 1979)|April 1, 1995
Short-term and sustained renal effects of angiotensin II receptor blockade in healthy subjectsM Burnier, M Hagman, J Nussberger, et al.Journal of Cardiovascular Pharmacology|February 25, 1998
Acute renal effects of AT1-receptor blockade after exogenous angiotensin II infusion in healthy subjectsF Schmitt, F Martinez, G Brillet, et al.British Journal of Obstetrics and Gynaecology|October 16, 1999
Receptor binding of oxytocin and vasopressin antagonists and inhibitory effects on isolated myometrium from preterm and term pregnant womenM Akerlund, T Bossmar, R Brouard, et al.European Journal of Clinical Pharmacology|January 1, 1993
Beta-adrenoceptor blockade potentiates acute exercise-induced release of atrial natriuretic peptide by increasing atrial diameter in normotensive healthy subjectsI Berlin, P Lechat, G Deray, et al.Rheumatology (Oxford, England)|October 18, 2000
Effect of SR 49059, a V1a vasopressin receptor antagonist, in Raynaud's phenomenonD Hayoz, G Bizzini, B Noël, et al.Cardiology|January 1, 1993
Tertatolol potentiates exercise-induced atrial natriuretic peptide release by increasing atrial diameter in healthy subjectsI Berlin, G Deray, P Lechat, et al.Hypertension (Dallas, Tex. : 1979)|December 22, 1999
Effects of the nonpeptide V(1) vasopressin receptor antagonist SR49059 in hypertensive patientsM Thibonnier, A Kilani, M Rahman, et al.Hypertension (Dallas, Tex. : 1979)|November 22, 1997
Effects of SR 49059, a new orally active and specific vasopressin V1 receptor antagonist, on vasopressin-induced vasoconstriction in humansR Weber, A Pechère-Bertschi, D Hayoz, et al.Advances in Experimental Medicine and Biology|February 23, 1999
Safety, tolerability, and pharmacokinetics of SR 49059, a V1a vasopressin receptor antagonist, after repeated oral administration in healthy volunteersR Brouard, V Laporte, C Serradeil Le Gal, et al.European Journal of Clinical Pharmacology|January 1, 1997
A drug interaction study between ticlopidine and cyclosporin in heart transplant recipientsP Boissonnat, M de Lorgeril, V Perroux, et al.Pageof 4